Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

NHS funding Wales

Breast cancer drug Kadcyla to be routinely available in Wales

her2 positive breast cancer cell

Source: Shutterstock.com

Patients in Wales with advanced HER2-positive breast cancer will have access to the treatment Kadcyla funded by the NHS

The breast cancer treatment Kadcyla (trastuzumab emtansine) will now be available routinely on the NHS in Wales after Roche, the drug’s manufacturer, agreed the same commercial access deal with NHS Wales as was recently agreed with NHS England.

Kadcyla is licensed to treat HER2-positive breast cancer that has spread to other parts of the body, cannot be surgically removed and has stopped responding to initial treatment. At full list price, treatment costs £90,000 per patient.

Funding for Kadcyla in Wales will initially come from the £80m new treatment fund that was announced by Welsh cabinet secretary for health Vaughan Gething in January 2017. In England, Kadcyla is currently funded through the Cancer Drugs Fund but, after a confidential agreement was reached between Roche and NHS England last week, the drug is expected to become routinely available on the NHS later this summer once current draft guidance from the National Institute for Health and Care Excellence, England’s health technology assessment body, gets ratified.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203038

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • her2 positive breast cancer cell

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.